Therapeutic Benefit of the Association of Lodenafil with Mesenchymal Stem Cells on Hypoxia-induced Pulmonary Hypertension in Rats
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Benefit of the Association of Lodenafil with Mesenchymal Stem Cells on Hypoxia-induced Pulmonary Hypertension in Rats
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 9, Pages 2120
Publisher
MDPI AG
Online
2020-09-18
DOI
10.3390/cells9092120
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intravenous Human Umbilical Cord-Derived Mesenchymal Stromal Cell Administration in Models of Moderate and Severe Intracerebral Hemorrhage
- (2020) Tanira Giara Mello et al. STEM CELLS AND DEVELOPMENT
- Beneficial Effects of Mesenchymal Stem Cell Delivery via a Novel Cardiac Bioscaffold on Right Ventricles of Pulmonary Arterial Hypertensive Rats
- (2019) Eric G. Schmuck et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Mesenchymal stem/stromal cell therapy for pulmonary arterial hypertension: Comprehensive review of preclinical studies
- (2019) Masafumi Fukumitsu et al. Journal of Cardiology
- MicroRNA-214-3p Regulates Hypoxia-Mediated Pulmonary Artery Smooth Muscle Cell Proliferation and Migration by Targeting ARHGEF12
- (2019) Xi-Qian Xing et al. MEDICAL SCIENCE MONITOR
- Mesenchymal Stem Cell Extracellular Vesicles Reverse Sugen/Hypoxia Pulmonary Hypertension in Rats
- (2019) James R Klinger et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery
- (2018) K-E Andersson BRITISH JOURNAL OF PHARMACOLOGY
- Synergistic interaction between a PDE5 inhibitor (sildenafil) and a new adenosine A2A receptor agonist (LASSBio-1359) improves pulmonary hypertension in rats
- (2018) Allan K. Alencar et al. PLoS One
- Inflammation in Right Ventricular Failure: Does It Matter?
- (2018) Laurence Dewachter et al. Frontiers in Physiology
- Haemodynamic definitions and updated clinical classification of pulmonary hypertension
- (2018) Gérald Simonneau et al. EUROPEAN RESPIRATORY JOURNAL
- Risk stratification and medical therapy of pulmonary arterial hypertension
- (2018) Nazzareno Galiè et al. EUROPEAN RESPIRATORY JOURNAL
- Periostin Mediates Right Ventricular Failure through Induction of Inducible Nitric Oxide Synthase Expression in Right Ventricular Fibroblasts from Monocrotaline-Induced Pulmonary Arterial Hypertensive Rats
- (2018) Keisuke Imoto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice
- (2018) Allan K. N. Alencar et al. Frontiers in Pharmacology
- Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model
- (2017) Marius M. Hoeper et al. EUROPEAN RESPIRATORY JOURNAL
- Mesenchymal Stem Cells Expressing eNOS and a Cav1 Mutant Inhibit Vascular Smooth Muscle Cell Proliferation in a Rat Model of Pulmonary Hypertension
- (2017) Haiying Chen et al. Heart Lung and Circulation
- Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension
- (2017) Lucas de Mendonça et al. Stem Cell Research & Therapy
- Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling
- (2017) Gesheng Cheng et al. Stem Cell Research & Therapy
- The cancer theory of pulmonary arterial hypertension
- (2017) Olivier Boucherat et al. Pulmonary Circulation
- Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats
- (2017) Makhosazane Zungu-Edmondson et al. PLoS One
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
- (2015) Nazzareno Galiè et al. EUROPEAN HEART JOURNAL
- Exploring the monocrotaline animal model for the study of pulmonary arterial hypertension: A network approach
- (2015) Rita Nogueira-Ferreira et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension
- (2014) Marc Humbert et al. CIRCULATION
- Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension
- (2014) Marlene Rabinovitch et al. CIRCULATION RESEARCH
- The Right Ventricle in Pulmonary Arterial Hypertension
- (2014) John J. Ryan et al. CIRCULATION RESEARCH
- Endothelin-1 driven proliferation of pulmonary arterial smooth muscle cells is c-fos dependent
- (2014) Valentina Biasin et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- N-acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity
- (2014) Allan K.N. Alencar et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Lodenafil treatment in the monocrotaline model of pulmonary hypertension in rats
- (2014) Igor Bastos Polonio et al. Jornal Brasileiro de Pneumologia
- Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertension
- (2014) Rhoda E. Kuc et al. LIFE SCIENCES
- The Sugen 5416/Hypoxia Mouse Model of Pulmonary Hypertension Revisited: Long-Term Follow-Up
- (2014) Sally H. Vitali et al. Pulmonary Circulation
- Paracrine Mechanisms of Mesenchymal Stem Cell-Based Therapy: Current Status and Perspectives
- (2013) Xiaoting Liang et al. CELL TRANSPLANTATION
- Long-term research of stem cells in monocrotaline-induced pulmonary arterial hypertension
- (2013) Yun Luan et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Sildenafil improves long-term effect of endothelial progenitor cell-based treatment for monocrotaline-induced rat pulmonary arterial hypertension
- (2013) Chia-Hung Yen et al. CYTOTHERAPY
- Pathology and Pathobiology of Pulmonary Hypertension
- (2013) Christophe Guignabert et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Exosomes Mediate the Cytoprotective Action of Mesenchymal Stromal Cells on Hypoxia-Induced Pulmonary Hypertension
- (2012) Changjin Lee et al. CIRCULATION
- A TRPC6-Dependent Pathway for Myofibroblast Transdifferentiation and Wound Healing In Vivo
- (2012) Jennifer Davis et al. DEVELOPMENTAL CELL
- Enhanced protection against pulmonary hypertension with sildenafil and endothelial progenitor cell in rats
- (2011) Cheuk-Kwan Sun et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension
- (2010) Dalia Urboniene et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Autocrine Fibroblast Growth Factor-2 Signaling Contributes to Altered Endothelial Phenotype in Pulmonary Hypertension
- (2010) Ly Tu et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- The Right Ventricle Under Pressure
- (2009) Harm J. Bogaard et al. CHEST
- Is the intravascular administration of mesenchymal stem cells safe?
- (2009) Dario Furlani et al. MICROVASCULAR RESEARCH
- Pharmacological characterization of a novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum
- (2008) Haroldo A. Toque et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started